JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bolt, M. W.
Right arrow Articles by Massey, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bolt, M. W.
Right arrow Articles by Massey, T. E.

Vol. 298, Issue 3, 1280-1289, September 2001

Disruption of Mitochondrial Function and Cellular ATP Levels by Amiodarone and N-Desethylamiodarone in Initiation of Amiodarone-Induced Pulmonary Cytotoxicity

M. W. Bolt, J. W. Card, W. J. Racz, J. F. Brien and T. E. Massey

Departments of Pharmacology and Toxicology (M.W.B., J.W.C., W.J.R., J.F.B., T.E.M.) and Medicine (T.E.M.), and School of Environmental Studies (T.E.M.), Queen's University, Kingston, Ontario, Canada

Amiodarone (AM), a potent antidysrhythmic agent, can cause potentially life-threatening pulmonary fibrosis. In the present investigation of mechanisms of initiation of AM lung toxicity, we found that 100 µM AM decreased mitochondrial membrane potential in intact hamster lung alveolar macrophages and preparations enriched in isolated alveolar type II cells and nonciliated bronchiolar epithelial (Clara) cells, following 2 h of incubation. This was followed by a drop in cellular ATP content (by 32-77%) at 4 to 6 h, and 30 to 55% loss of viability at 24 h. Supplementation of incubation media with 5.0 mM glucose or 2.0 mM niacin did not reduce AM-induced ATP depletion or cell death in macrophages, and the mitochondrial permeability transition inhibitor cyclosporin A (1.0 µM) did not affect AM cytotoxicity. At 50 µM, the AM metabolite N-desethylamiodarone (DEA) produced effects similar to those of AM, but more rapidly and extensively, with the Clara cell-enriched preparation being particularly susceptible. In isolated whole lung mitochondria, DEA was accumulated to a greater extent than AM. Both AM and DEA inhibited complex I- and complex II-supported respiration, but DEA inhibited complex II to a greater degree than AM. These results demonstrate that AM and DEA disrupt mitochondrial membrane potential prior to ATP depletion and subsequent lung cell death, that DEA is more potent than AM, and that the mitochondrial permeability transition is not involved in mitochondrial perturbation by AM. This suggests that AM- and DEA-induced perturbations of mitochondrial function may initiate AM-induced pulmonary toxicity.

0022-3565/01/2983-1280$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
A. Breitenstein, S.F. Stampfli, G.G. Camici, A. Akhmedov, H.R. Ha, F. Follath, A. Bogdanova, T.F. Luscher, and F.C. Tanner
Amiodarone Inhibits Arterial Thrombus Formation and Tissue Factor Translation
Arterioscler Thromb Vasc Biol, December 1, 2008; 28(12): 2231 - 2238.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. B. Fernandez, R. H. Karas, A. A. Alsheikh-Ali, and P. D. Thompson
Statins and Interstitial Lung Disease: A Systematic Review of the Literature and of Food and Drug Administration Adverse Event Reports
Chest, October 1, 2008; 134(4): 824 - 830.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. A. Sarafian, N. Habib, M. Oldham, N. Seeram, R.-P. Lee, L. Lin, D. P. Tashkin, and M. D. Roth
Inhaled marijuana smoke disrupts mitochondrial energetics in pulmonary epithelial cells in vivo
Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1202 - L1209.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
J. S. Mader, J. Salsman, D. M. Conrad, and D. W. Hoskin
Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines
Mol. Cancer Ther., April 1, 2005; 4(4): 612 - 624.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
T. C. McCarthy, P. T. Pollak, E. A. Hanniman, and C. J. Sinal
Disruption of Hepatic Lipid Homeostasis in Mice after Amiodarone Treatment Is Associated with Peroxisome Proliferator-Activated Receptor-{alpha}Target Gene Activation
J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 864 - 873.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
G. Varbiro, A. Toth, A. Tapodi, Z. Bognar, B. Veres, B. Sumegi, and F. Gallyas Jr.
Protective Effect of Amiodarone but Not N- Desethylamiodarone on Postischemic Hearts through the Inhibition of Mitochondrial Permeability Transition
J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 615 - 625.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. W. Card, W. J. Racz, J. F. Brien, S. B. Margolin, and T. E. Massey
Differential Effects of Pirfenidone on Acute Pulmonary Injury and Ensuing Fibrosis in the Hamster Model of Amiodarone-Induced Pulmonary Toxicity
Toxicol. Sci., September 1, 2003; 75(1): 169 - 180.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. W. Card, W. J. Racz, J. F. Brien, and T. E. Massey
Attenuation of Amiodarone-Induced Pulmonary Fibrosis by Vitamin E Is Associated with Suppression of Transforming Growth Factor-beta 1 Gene Expression but Not Prevention of Mitochondrial Dysfunction
J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 277 - 283.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.